According to Nectar Lifesciences latest financial reports the total debt is $27.00M, an decrease of -22.19% to 2022. At the end of 2022 company had $34.70M total debt. This figure represents the debts and financial obligations that Nectar Lifesciences combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $27.00M | -22.19% |
2022 | $34.70M | 126.98% |
2021 | $15.29M | 5.56% |
2020 | $14.48M | -26.64% |
2019 | $19.74M | - |